Everest Organics Limited
EVERESTO.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.34B
Close$
$-131.10
158.1% downside
Current Fair Value
158.1% downsideOvervalued by 158.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.34 Billion |
|---|---|
| Enterprise Value | $2.34 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $5.7 |
| Beta | 0.54 |
| Outstanding Shares | 9,710,526 |
Return
| Return on Equity | 6.96% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 44.56 |
|---|---|
| PEG | -214.61 |
| Price to Sales | 1.15 |
| Price to Book Ratio | 2.93 |
| Enterprise Value to Revenue | 1.22 |
| Enterprise Value to EBIT | 17.39 |
| Enterprise Value to Net Income | 44 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Everest Organics Limited
316 employees
CEO: Sirisha Sri Kakarlapudi Everest Organics Limited is a pharmaceutical enterprise specializing in the production of bulk drugs. Its product line encompasses compounds such as Omeprazole, Ciprofloxacin, Dichloroflurobenzene, and Benzimadizole. Additionally, the co...